Legacy Capital Wealth Partners LLC Sells 338 Shares of The Procter & Gamble Company (NYSE:PG)

Legacy Capital Wealth Partners LLC decreased its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 6.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,060 shares of the company’s stock after selling 338 shares during the period. Legacy Capital Wealth Partners LLC’s holdings in Procter & Gamble were worth $876,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the company. Concurrent Investment Advisors LLC grew its holdings in Procter & Gamble by 4.5% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after acquiring an additional 4,035 shares during the last quarter. Radnor Capital Management LLC bought a new stake in shares of Procter & Gamble during the third quarter valued at approximately $5,705,000. Welch Group LLC increased its holdings in shares of Procter & Gamble by 0.9% in the third quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after purchasing an additional 2,990 shares in the last quarter. GAMMA Investing LLC raised its position in Procter & Gamble by 67.2% in the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after purchasing an additional 10,777 shares during the last quarter. Finally, Quintet Private Bank Europe S.A. lifted its holdings in Procter & Gamble by 15.0% during the 3rd quarter. Quintet Private Bank Europe S.A. now owns 426,820 shares of the company’s stock worth $73,925,000 after buying an additional 55,620 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft lifted their target price on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Morgan Stanley lifted their price objective on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. Evercore ISI boosted their price objective on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Finally, DA Davidson boosted their price target on shares of Procter & Gamble from $159.00 to $160.00 and gave the stock a “neutral” rating in a research note on Monday, October 21st. Nine equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $177.00.

Check Out Our Latest Report on PG

Procter & Gamble Price Performance

Shares of PG opened at $167.71 on Friday. The stock has a 50 day simple moving average of $171.08 and a 200 day simple moving average of $168.15. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $177.94. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The firm has a market capitalization of $394.96 billion, a PE ratio of 28.92, a P/E/G ratio of 3.48 and a beta of 0.42.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. During the same quarter in the prior year, the company earned $1.83 earnings per share. The business’s quarterly revenue was down .6% compared to the same quarter last year. Sell-side analysts predict that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.40%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio is 69.31%.

Insider Activity

In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares of the company’s stock, valued at $6,325,360. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In related news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the sale, the insider now owns 11,566 shares of the company’s stock, valued at approximately $1,954,538.34. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Andre Schulten sold 13,041 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the transaction, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at $6,325,360. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 313,597 shares of company stock worth $53,268,499 over the last three months. Corporate insiders own 0.18% of the company’s stock.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.